Loading organizations...
§ Venture Capital · Huangpu, China
Venture capital fund investing in medical and healthcare technology startups, focusing on medical devices and diagnostics.
Huangpu Medical Fund is a Shanghai, China-based venture capital fund that invests in early- to growth-stage medical and healthcare technology startups, primarily participating in follow-on financing rounds for innovative companies developing advanced medical devices and diagnostics. The fund has supported portfolio companies such as Tingsheng Technology, which focuses on intracardiac ultrasound technology and recently secured nearly 100 million yuan in its Series B+ round. Additionally, Huangpu Medical Fund participated in GRAIL's oversubscribed $300 million Series C financing, a company specializing in early cancer detection technologies. The firm frequently co-invests alongside other prominent venture capital firms, including Qiming Venture Partners, Yifeng Capital, Sequoia Capital China, and Hillhouse Capital Group, across various healthcare and life sciences ventures. Founding details for Huangpu Medical Fund are not publicly available.
Huangpu Medical Fund has 1 tracked investment across 1 company. The latest tracked deal is $1.3M Series A in Juncell Therapeutics in January 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 15, 2022 | Juncell Therapeutics | $1.3M Series A | — | BioVenture, Huaige Capital, Huayi Capital, Kaitai Capital |